Climb Biotherapeutics, Inc. (CLYM)
Market Closed
18 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
14. 05
-0.01
-0.0711%
$
805.12M Market Cap
- P/E Ratio
- Div Yield
4.05M Volume
0 Eps
$ 14.06
Previous Close 
Want to track CLYM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Climb Biotherapeutics, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Mayank Mamtani B. Riley Securities | 8,736.83 | $135,595.58 | $123,860.27 | -$11,735.31 | -8.65% |
